Altogether, their results suggested that miR-373 up-regulation and SIRT1 down-regulation induced cell death in pancreatic cancerous cells by suppressing the PGC-1α/ Nrf2 pathway, which could highlight miR-373 as a therapeutic target in pancreatic cancer [106]. This evidence concerns the gene SIRT1 and familial pancreatic carcinoma.